Psoriatic arthritis injection trial ends early – safety data collected
NCT ID NCT06522035
First seen Apr 25, 2026 · Last updated May 17, 2026 · Updated 7 times
Summary
This early-stage study tested an experimental drug called Allocetra, given as a shot into the joint, for people with psoriatic arthritis. The main goal was to check safety and side effects. Only 5 people took part, and the study was stopped early, so we don't have clear results on how well it works.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ARTHRITIS, PSORIATIC are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Carmel Medical Center
Haifa, 3436212, Israel
-
Meir Medical Center
Kfar Saba, 4428164, Israel
-
Rambam Medical Center
Haifa, 3109601, Israel
-
Tel Aviv Sourasky Medical Center - Ichilov
Tel Aviv, 6423906, Israel
Conditions
Explore the condition pages connected to this study.